TOMI to Highlight Its State-of-the-Art Decontamination Technology—SteraMist/BIT (Binary Ionization Technology) at APIC 2013

0

Source: TOMI Environmental Solutions, Inc.

TOMI Environmental Solutions, Inc. announces that it will showcase its SteraMist Technology at APIC to be held at the Greater Ft. Lauderdale-Broward County Convention Center June 8-10, 2013 in Ft. Lauderdale, Florida.

BEVERLY HILLS, Calif.--(BUSINESS WIRE)-- TOMI Environmental Solutions, Inc. (“TOMI” or the “Company”) (OTCQB: TOMZ), a global bacteria decontamination and infectious disease control company, announces that it will showcase its SteraMist System at the Association for Professionals in Infection Control and Epidemiology (APIC) 2013 annual education conference and international meeting to be held June 8-10, 2013 in Fort Lauderdale, Florida. SteraMist/BIT’s (Binary Ionization Technology) is an innovative, patented no-touch technology which utilizes an activated aerosolized hydrogen peroxide (H2O2) to effectively address bio-decontamination situations, on all micro-organisms.

According to the Conference website, “Each year more than 2,500 clinical professionals from around the world gather for three days to advance their network and learn about evidence-based advances in infection prevention.” The site goes on to inform attendees that they will, “Learn more about new science, technologies, advances, and products that provide solutions to your infection prevention challenges and strengthen your infection prevention program.”

Based on feedback, one of the most anticipated technologies that will be on display is TOMI’s SteraMist handheld portable room decontamination unit. This technology is the world’s only portable hydrogen peroxide handheld device for use by hospitals’ EVS staff, to achieve superior hospital surface decontamination within 10 minutes in areas of where HAIs are a concern.

TOMI’s patented technology of activating a proprietary solution (including less than 8% hydrogen peroxide) is referred to as Activated Hydrogen Peroxide (AHP). TOMI’s SteraMist/BIT has been proven effective against superbugs such as MRSA and C. difficile, and all the remaining ESKAPE bacteria.

Studies show that healthcare associated infections take the lives of nearly 271 people in the U.S. every day and add between $30 billion to $50 billion to U.S. healthcare costs.

Dr. Halden Shane, TOMI’s Chief Executive Officer, stated, “TOMI, Inc. will be demonstrating its SteraMist Technology at booth #1024. Healthcare professionals will be able to see firsthand how easy SteraMist is to use.”

About TOMI Environmental Solutions, Inc.

TOMI Environmental Solutions, Inc. (OTCQB: TOMZ) is a global bacteria decontamination and infectious disease control company, providing green energy-efficient environmental solutions for indoor surface decontamination through manufacturing, sales and licensing of our premier platform of Hydrogen Peroxide aerosols, Ultra-Violet Ozone Generators and Ultra-Violet Germicidal Irradiation ('UVGI') products and technologies.

TOMI’s products are designed to service a broad spectrum of commercial structures including medical facilities, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, and athletic facilities. TOMI’s products and services have also been used in single-family homes and multi-unit residences.

TOMI also develops training programs and application protocols for its clients and is a member in good standing with the Indoor Air Quality Association, The International Ozone Association and The United States Green Building Council, The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America and the Restoration Industry Association.

For additional product information, visit TOMI’s website at www.tomiesinc.com.

For more information, visit TOMI at booth #1024 or contact us at info@tomiesinc.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Certain written and oral statements made by us may constitute “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Forward-looking statements are identified by such words and phrases as “we expect,” “expected to,” “estimates,” “estimated,” “current outlook,” “we look forward to,” “would equate to,” “projects,” “projections,” “projected to be,” “anticipates,” “anticipated,” “we believe,” “could be,” and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. Because they are forward-looking, they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release.

Customer comments

No comments were found for TOMI to Highlight Its State-of-the-Art Decontamination Technology—SteraMist/BIT (Binary Ionization Technology) at APIC 2013. Be the first to comment!